[1]
J. Zhu, R. Zhou, and H. Xiao, “Mental disorder or conscious disturbance in epidermal growth factor receptor-tyrosine kinase inhibitor treatment of advanced lung adenocarcinoma”, EXCLI J., vol. 19, pp. 230–238, Feb. 2020.